Patents by Inventor Felix M. Dietrich

Felix M. Dietrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen derivatives and processes for their preparation
    Patent number: 4574058
    Abstract: The invention relates to novel antigen derivatives comprising an antigen and at least one muramylpeptide covalently bonded thereto, if appropriate via a spacer, to pharmaceutical preparations which contain such compounds and to their use as a vaccine.The novel antigen derivatives produce a pronounced increase in the immuno-response to the antigen, and in particular also a cell-medicated immunity under clinically acceptable conditions of administration.
    Type: Grant
    Filed: March 21, 1983
    Date of Patent: March 4, 1986
    Assignee: Ciba-Geigy Corporation
    Inventors: Gerhard Baschang, Felix M. Dietrich, Roland Gisler, Albert Hartmann, Jaroslav Stanek, Lajos Tarcsay
  • Antigen derivatives and processes for their preparation
    Patent number: 4446128
    Abstract: The invention relates to novel antigen derivatives comprising an antigen and at least one muramyl-peptide covalently bonded thereto, if appropriate via a spacer, to pharmaceutical preparations which contain such compounds and to their use as a vaccine.The novel antigen derivatives produce a pronounced increase in the immuno-response to the antigen, and in particular also a cell-medicated immunity under clinically acceptable conditions of administration.
    Type: Grant
    Filed: May 18, 1982
    Date of Patent: May 1, 1984
    Assignee: Ciba-Geigy Corporation
    Inventors: Gerhard Baschang, Felix M. Dietrich, Roland Gisler, Albert Hartmann, Jaroslav Stanek, Lajos Tarcsay
  • Antigen derivatives and processes for their preparation
    Patent number: 4397844
    Abstract: The invention relates to novel antigen derivatives comprising an antigen and at least one muramylpeptide covalently bonded thereto, if appropriate via a spacer, to pharmaceutical preparations which contain such compounds and to their use as a vaccine.The novel antigen derivatives produce a pronounced increase in the immuno-response to the antigen, and in particular also a cell-medicated immunity under clinically acceptable conditions of administration.
    Type: Grant
    Filed: September 17, 1981
    Date of Patent: August 9, 1983
    Assignee: Ciba-Geigy Corporation
    Inventors: Gerhard Baschang, Felix M. Dietrich, Roland Gisler, Albert Hartmann, Jaroslav Stanek, Lajos Tarcsay